Pharmaceutical

JY-302 by Jin Yang Pharmaceutical for Type 2 Diabetes: Likelihood of Approval

JY-302 is under clinical development by Jin Yang Pharmaceutical and is currently in the Phase I in clinical pathway.

Aug 10, 2023 - 20:00
JY-302 is under clinical development by Jin Yang Pharmaceutical and is currently in the Phase I in clinical pathway.
Read the original article

Tags:

Previous Article

STAT+: Beleaguered drug manufacturer Emergent cuts jobs, executive role in busin...

Next Article

KKM-191-D by Genuone Science for Type 2 Diabetes: Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

AB Science announces Canadian patent for masitinib to treat ALS

AB Science announces Canadian patent for masitinib to t...

Jun 3, 2023

A young girl’s custom gene therapy hints at a framework for tailored rare disease treatments

A young girl’s custom gene therapy hints at a framework...

Jul 12, 2023

Regeneron and Sonoma Biotherapeutics partner to develop T cell therapies

Regeneron and Sonoma Biotherapeutics partner to develop...

Mar 29, 2023